Rx Labeling Should Be Left To Manufacturers, Not FDA, Pfizer Says

FDA should allow manufacturers to choose the exact wording of required substantive information in their labels, 1Pfizer's comments on First Amendment issues state

More from Archive

More from Pink Sheet